About
Acera Surgical is a bioscience company based in St. Louis, Missouri, founded in 2013. The company specializes in developing and commercializing synthetic materials for regenerative medicine, particularly in soft-tissue repair. Acera Surgical originated from research led by Dr. Matthew MacEwan at Washington University, focusing on polymer biomaterials and electrospun fiber technology. The company's key innovation is its proprietary electrospun fiber matrix technology, which creates sub-cellular-sized fibers that mimic human tissue. Their products include Cerafix, the first FDA-cleared electrospun dura substitute in the U.S., designed for repairing the dura mater, and Restrata, a fully resorbable fiber matrix for soft-tissue repair and wound management. Acera Surgical aims to enhance patient healing and quality of life through innovative medical devices, targeting healthcare providers in surgical and wound care settings.
Technologies
Keywords
Company Information
- Employees170
- Founded2013
- Annual Revenue$4700000
- Total Funding$134885000
Location
1650 Des Peres Rd, St. Louis, Missouri, United States, 63131-1821
